Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0130
0.00 (0.00%)
Jan 8, 2026, 4:00 PM EST
Emmaus Life Sciences Market Cap
Emmaus Life Sciences has a market cap or net worth of $830.25 thousand as of January 9, 2026. Its market cap has decreased by -87.76% in one year.
Market Cap
830.25K
Enterprise Value
32.22M
Revenue
11.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since July 18, 2019, Emmaus Life Sciences's market cap has decreased from 353.30M to 830.25K, a decrease of -99.77%. That is a compound annual growth rate of -60.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 830.25K | - |
| Dec 31, 2025 | 830.25K | 52.94% |
| Dec 31, 2024 | 542.86K | -91.23% |
| Dec 29, 2023 | 6.19M | -52.02% |
| Dec 30, 2022 | 12.90M | -84.34% |
| Dec 31, 2021 | 82.35M | 36.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 781.81M |
| Glass House Brands | 714.29M |
| Elite Pharmaceuticals | 527.53M |
| Northwest Biotherapeutics | 499.37M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 280.10M |